Proscia, Ibex, and Quest Diagnostics Webinar: Quantifying the Value of AI-Powered Digital WorkflowsSIGN UP
Pathology

at Life Speed

Content to help accelerate life sciences R&D

 

About Pathology at Life Speed

Pathology at Life Speed is a webinar series featuring industry leaders discussing topics designed to help biopharma companies, biotechs, CROs, academic research centers and commercial laboratories to unlock the full potential of pathology and precision medicine.

Watch one of our webinars or tour Concentriq to see just how fast life sciences R&D can go with digital pathology.   

ON DEMAND WEBINAR

From Bedside to Bench and Back: How Digital Pathology is Fueling Precision Medicine with Unprecedented Real-World Data (RWD)

Each pathology image generated through the digitization of diagnostic workflows contains billions of pixels and powerful insights that can be leveraged to accelerate drug discovery and development. In this webinar, industry leaders from Genentech and PathGroup share how they are harnessing this valuable data to drive the next breakthroughs in precision medicine.

 Gain an understanding of the value of RWD, with a deeper appreciation for the critical role clinical laboratories play, not only in delivering today’s precision medicines diagnostics, but in advancing the novel diagnostics and therapies of tomorrow.

WATCH THE WEBINAR

Scott Gottlieb
DEREK WELCH, MD, FCAP

Chief Medical Officer

PathGroup

Christopher Molineaux
BEN FREIBERG, PhD

Principal Informatics Systems Lead, gCS Computational Catalysts

Genentech, A Member of the Roche Group

NATHAN BUCHBINDER

Chief Strategy Officer

Proscia

ON DEMAND WEBINAR

Streamlining Clinical Development and Maximizing Trial Success with an Enterprise Pathology Platform

Complex global logistics and a lack of standardized processes have limited the effectiveness of digital pathology in clinical trials until only recently. IQVIA Laboratories shares their vision for the future of clinical trials and clinical development using enterprise pathology to deliver global access to more patients, laboratories, and pathology leaders. 

Learn about the potential advantages that streamlined and centralized clinical trials offer to maximize trial success with enhanced workflow efficiency, and new opportunities for collaboration and clinical insights.

WATCH THE WEBINAR

Scott Gottlieb
AMANDA HEMMERICH, MD

Director of Digital Pathology Innovation

IQVIA Laboratories

Christopher Molineaux
JOHN COCHRAN, MD, FCAP

Chief Medical Officer and Chief Pathologist

IQVIA Laboratories

NATHAN BUCHBINDER

Chief Strategy Officer

Proscia

ON DEMAND WEBINAR

Unlocking the Promise of Foundation Models in Pathology For AI-Driven Drug Discovery & Development

Hear from scientific experts in computational pathology, AI, and biology as they explore how foundation models are transforming AI development and accelerating breakthroughs in precision medicine. In this webinar, our experts will provide a closer look into the world’s largest open-source AI foundation model for pathology, H-optimus-0 from Bioptimus.

 Learn practical strategies for maximizing its value, and real-world applications where downstream AI algorithms built leveraging foundation models such as H-optimus-0 are already impacting drug discovery, clinical trials, and more

WATCH THE WEBINAR

Scott Gottlieb
ZELDA MARIET

Co-founder & Principal Research Scientist

Bioptimus

Christopher Molineaux
JULIANNA IANNI

Vice President, AI Research & Development

Proscia

Christopher Molineaux
COREY CHIVERS

Senior AI Scientist

Proscia

PRODUCT TOUR
Concentriq

Serving as the central hub for AI-enabled scientific workflows from biomarker discovery to clinical trial execution, Concentriq LS unifies data, teams, and applications to unlock insights and accelerate R&D pipelines. 

Sign up for a Product Tour to see what’s possible with the enterprise pathology platform for AI-driven therapeutic R&D.

TOUR CONCENTRIQ

See how fast life sciences research can go with digital pathology.

Our website uses cookies. By using this site, you agree to its use of cookies.